Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-products/calcitonin-ria-kit-11847-1/;msg18067;topicseen) was not found.

Search medicine products calcitonin ria kit 11847 1 ;msg18067;topicseen at Google

Search medicine products calcitonin ria kit 11847 1 ;msg18067;topicseen at Yahoo

Search medicine products calcitonin ria kit 11847 1 ;msg18067;topicseen at Msn

Google
 
(Date:12/3/2009)...eam of scientists from the U.S. Department of Ener... University, and the Indian Institute of Science h...s locate the genetic information in DNA that is ne...s. The research, published in the December 1, 2009... , confirms that many proteins responsible for int...
(Date:12/2/2009)...IA Less acculturated Latino men have a more diffi... acculturated to U.S. culture, but acculturation h...Details of these findings are published in Cancer... of the American Association for Cancer Research. ... , "Acculturation affects smoking cessation diff...
(Date:12/2/2009)...IA People who smoke their first cigarette within ... cotinine, a by-product of nicotine when processed...less of the number of cigarettes smoked. , "S... lung cancer, our results suggest that smokers who...at risk for lung cancer," said researcher Joshua E...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2Increased nicotine levels detected in those who light-up earlier 2Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 1Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 2Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 3Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 4Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 5Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 6AMICAS Set to Join Russell 3000 Index 49217 1AMICAS Set to Join Russell 3000 Index 49217 2AMICAS Set to Join Russell 3000 Index 49217 3Alan Stein D D S Opens His Doors and Empties His Pockets 49215 1Alan Stein D D S Opens His Doors and Empties His Pockets 49215 2
(Date:12/4/2009)..., ANAHEIM, Calif., Dec. 4 Pamela ...hcare, was selected as a finalist for the "Chief I...scent,s business with the power of cloud computing...ir innovative usage of Salesforce CRM or the Force...uccess to their sales, marketing, partner, service...
(Date:12/4/2009)... with mice, scientists at Johns Hopkins publishing...hat a protein made by a gene called "Twist" may be...nguish stem cells that drive aggressive, metastati..., Building on recent work suggesting that it is a ...umors that drives breast cancer, scientists have s...
(Date:12/4/2009)...me whether procedure done immediately or 3 weeks l...althDay News) -- Timing of surgical repair or reco...not affect patient outcome, a new study has found....traumatic knee dislocations that can occur in high...mal time to perform surgery to repair these injuri...
(Date:12/4/2009)...d surveillance urged for at-risk patient groups ,...e childhood cancers, particularly Ewing sarcomas a...f late recurrence, U.S. researchers have found. ,...e-year survivors of the most common pediatric canc...ivor Study. , The researchers found that the ov...
(Date:12/4/2009)... found they spurred blood vessel growth after hear...ews) -- Adult stem cells appear to help repair hea...e 1 study of 53 patients found that stem cells fro...od vessels in heart tissue damaged by heart attack...ons within 10 days of having a heart attack. Durin...
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
Cell Proliferation Kit from GE Healthcare, formerly Amersham Biosciences
Goat Anti-Human Dysadherin 2 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-Human Bcl-2, phospho (Thr74) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Trx-2 Monoclonal Antibody, Unconjugated, Clone 71G4 from Santa Cruz Biotechnology, Inc.
Biology Products:
Disposable Lacrimal Dilators
Reusable Double Dilators
Skin Tone External Eyelid Weights
Contour Design Eyelid Implants (Gold)
Medicine Products:
(Date:12/2/2009)...wswire-FirstCall/ - Oncolytics Biotech Inc. ("Onco... announced today that in connection with its previ...ve exercised in full their over-allotment option a...t is comprised of one common share and 0.4 of a co...ce of US$3.00 per unit. Each whole common share pu...
(Date:12/2/2009)..., December 2 Gamida Cell announced...cal (animal study) safety and,efficacy of a gene t...l,Cornell Medical College and Gamida Cell. The pro... such as Cooley,s Anemia. , Gamida Cell i...x vivo,populations of stem/progenitor cells. The ...
(Date:12/2/2009)...ire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: A...aceutical company focused on endocrine therapy and...Drug Administration (FDA) has granted Fast Track d...bitor compound, perifosine (KRX-0401), for the tre...ryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), is...
(Date:12/1/2009)...mon announced that he has joined Carolina Eyecare ... at www.DrKerrySolomon.com , which was developed ...ven LASIK, lens implant, and cataract surgery expe...substantial contributions to improving vision corr...urgeons, which screens LASIK surgeons based upon e...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
(Date:12/4/2009)...c. 4 Suneva Medical, a privately-h...ced the appointment of Philip Ranker as Vice Presi...r. Ranker will lead all Suneva Medical,s general a...ounting, IT, IR, administration and human resource...agement team. ,, "One of my key objectives as ...
(Date:12/4/2009)... Drs. Neal Shore and E. David Crawf...n (PSA) recurrence from the additional analysis of...te in a Phase III pivotal study of FIRMAGON® ...olide in prostate cancer patients during the first...received FIRMAGON 240/80 mg/month had a recurrence...
(Date:12/3/2009)... Allen Medical Systems, ...RC ), today announced the launch of its new Allen ...business website www.AllenAmatech.com . ,, ... identity and includes an online version of the ne...design specifications for the products. "We hope t...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 1Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 2Accelerated Development of New Treatment for Multi Drug Resistant Tuberculosis 3A TB Alliance and Tibotec Announce Unique Partnership to Develop TMC20 49213 3AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 1AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 2AMDL CEO Featured in CEOCFO Magazine 3B Details Progress on DR 70 International Commercialization Strategy 26 Confidence in FY2009 Financial Forecast 49211 3Hartford grants increase support for geriatric social work training 49209 1Hartford grants increase support for geriatric social work training 49209 2Hartford grants increase support for geriatric social work training 49209 3